Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH).
- Disclosed ownership: 7.8%.
- Date of event: 31 Mar 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 7.8% ownership in Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH) on 31 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 7.8% | 3,910,304 | 0 | 3,910,304 | /s/ Kevin Tang | Manager | |
| KEVIN TANG | 7.8% | 3,910,304 | 0 | 3,910,304 | /s/ Kevin Tang | Self | |
| TANG CAPITAL PARTNERS, LP | 7.3% | 3,656,983 | 0 | 3,656,983 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0.45% | 223,321 | 0 | 223,321 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0.05% | 24,000 | 0 | 24,000 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0.01% | 6,000 | 0 | 6,000 | /s/ Kevin Tang | Chief Executive Officer |